Analysis of Facebook publications and comments about ivermectin during the COVID-19 pandemic in Peru
Keywords:
ivermectin, social network, social perception, COVID-19, Peru.Abstract
The purpose of the study was to analyze Facebook publications and perceptions of users, expressed in their comments, about the drug ivermectin during the COVID-19 pandemic in Peru. The publications and their comments were selected by manual search using the terms “ivermectin” and “#ivermectin” in July 2020. Interpretation of publications and their comments was performed by conventional qualitative content analysis with inductive processing and supported by scientific literature. A total 17 publications were retrieved from the period extending from 18 May to 7 July 2020. These were classified into five topics: rumors (58.8%), based on scientific evidence (11.8%), caution (11.8%), production of the drug (11.8%) and confrontation (5.9%). Paradoxically, 70.0% of the rumors were spread by mass media pages. Comments, on the other hand, were classified into four topics based on user perceptions: ivermectin as “effective cure” (64.8%), request for information about ivermectin (25.3%), against the use of ivermectin (6.3%) and other treatments (3.6%). As a conclusion, it was found that more than half of the information about ivermectin circulating in Facebook publications is classified as “rumors”, and most is spread by mass media pages. Analysis of the comments found that user perception considers ivermectin to be the “effective cure” against COVID-19.
Downloads
References
Chaccour C, Hammann F, Ramón García S, Rabinovich NR. Ivermectin and COVID-19: Keeping rigor in times of urgency. Am J Trop Med Hyg. 2020;102(6):1156-7. DOI: https://doi.org/10.4269/ajtmh.20-0271
Sharun K, Shyamkumar TS, Aneesha VA, Dhama K, Pawde AM, Pal A. Current therapeutic applications and pharmacokinetic modulations of ivermectin. Vet World. 2019;12(8):1204-11. DOI: https://doi.org/10.14202/vetworld.2019.1204-1211
Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 2020;178:104787. DOI: https://doi.org/10.1016/j.antiviral.2020.104787
BBC News Mundo. La ivermectina y otros medicamentos sin eficacia probada contra el coronavirus que se promueven en América Latina. Londres: BBC; 2020 [acceso 13/02/2021]. Disponible en: https://www.bbc.com/mundo/noticias-america-latina-53389727
Organización Panamericana de la Salud. Recomendación sobre el uso de ivermectina para el tratamiento de la COVID-19. Washington D.C.: OPS; 2020 jun [acceso 13/02/2021]. Disponible en: https://iris.paho.org/bitstream/handle/10665.2/52379/OPSIMSCDECOVID-19200033_spa.pdf
Food and Drug Administration. FAQ: COVID-19 and Ivermectin intended for animals. Maryland: FDA; 2020 [acceso 13/02/2021]. Disponible en: https://www.fda.gov/animal-veterinary/product-safety-information/faq-covid-19-and-ivermectin-intended-animals
Pan-American Health Organization. Ongoing living update of COVID-19 therapeutic options: summary of evidence. Washington D.C.: PAHO; 2020 dic [acceso 13/02/2021]. Disponible en: https://iris.paho.org/bitstream/handle/10665.2/52719/PAHOIMSEIHCOVID-19200030_eng.pdf
Salud con lupa. ¿Es peligroso automedicarse con ivermectina? Lima: Salud con lupa; 2020 jul [acceso 13/02/2021]. Disponible en: https://saludconlupa.com/comprueba/es-peligroso-automedicarse-con-ivermectina/
El Peruano. Resolución Ministerial N.° 947-2020-MINSA, Aprueban documento técnico: Manejo ambulatorio de personas afectadas por la COVID-19 en el Perú. Lima: El Peruano; 2020 nov [acceso 13/02/2021]. Disponible en: https://busquedas.elperuano.pe/normaslegales/aprueban-documento-tecnico-manejo-ambulatorio-de-personas-a-resolucion-ministerial-n-947-2020minsa-1905323-2/
Soto A. The use of drugs without demonstrated effect as a therapeutic strategy in COVID-19 in Peru. Acta Med Peru. 2020;37(3). DOI: https://doi.org/10.35663/amp.2020.373.1548
El Comercio. Autoridades reparten ivermectina para vacas para tratar pacientes con coronavirus en Ucayali. Lima: El Comercio; 2020 mayo [acceso 13/02/2021]. Disponible en: https://elcomercio.pe/tecnologia/ciencias/coronavirus-ivermectina-covid-19-en-ucayali-autoridades-reparten-ivermectina-para-animales-para-tratar-pacientes-con-coronavirus-noticia/
The Scientist Magazine. Surgisphere sows confusion about another unproven COVID-19 drug. New York: The Scientist; 2020 jun [acceso 13/02/2021]. Disponible en: https://www.the-scientist.com/news-opinion/surgisphere-sows-confusion-about-another-unproven-covid19-drug-67635#.XuvRkGUQfjI.email
Naeem S Bin, Bhatti R, Khan A. An exploration of how fake news is taking over social media and putting public health at risk. Health Info Libr J. 2020;38(2):143-9. DOI: https://doi.org/10.1111/hir.12320
Wang Z, Ye X. Social media analytics for natural disaster management. Int J Geogr Inf Sci. 2018;32(1):49-72. DOI: https://doi.org/10.1080/13658816.2017.1367003
Pan-American Health Organization. Entender la infodemia y la desinformación en la lucha contra la COVID-19. Washington D.C.: PAHO; 2020 [acceso 10/03/2021]. Disponible en: https://iris.paho.org/handle/10665.2/52053
Shorey S, Ang E, Yamina A, Tam C. Perceptions of public on the COVID-19 outbreak in Singapore: a qualitative content analysis. J Public Health (Bangkok). 2020;42(4):665-71. DOI: https://doi.org/10.1093/pubmed/fdaa105
Islam MS, Sarkar T, Khan SH, Kamal A-HM, Hasan SMM, Kabir A, et al. COVID-19–related infodemic and its impact on public health: a global social media analysis. Am J Trop Med Hyg. 2020;103(4):1621. DOI: https://doi.org/10.4269/ajtmh.20-0812
El-Awaisi A, O’Carroll V, Koraysh S, Koummich S, Huber M. Perceptions of who is in the healthcare team? A content analysis of social media posts during COVID-19 pandemic. J Interprof Care. 2020;34(5):622-32. DOI: https://doi.org/10.1080/13561820.2020.1819779
Tsao SF, Chen H, Tisseverasinghe T, Yang Y, Li L, Butt ZA. What social media told us in the time of COVID-19: a scoping review. Lancet Digit Heal. 2021;3(3):e175. DOI: https://doi.org/10.1016/S2589-7500(20)30315-0
We Are Social. DIGITAL 2021. Londres: We Are Social; 2021 [acceso 15/02/2021]. Disponible en: https://wearesocial.com/digital-2021
Hu D, Lou X, Xu Z, Meng N, Xie Q, Zhang M, et al. More effective strategies are required to strengthen public awareness of COVID-19: Evidence from google trends. J Glob Health. 2020;10(1):011003. DOI: https://doi.org/10.7189/jogh.10.011003
Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277-88. DOI: https://doi.org/10.1177/1049732305276687
Eysenbach G, Till JE. Ethical issues in qualitative research on internet communities. Br Med J. 2001;323(7321):1103-5. DOI: https://doi.org/10.1136/bmj.323.7321.1103
Mheidly N, Fares J. Leveraging media and health communication strategies to overcome the COVID-19 infodemic. J Public Health Policy. 2020;1-11. DOI: https://doi.org/10.1057/s41271-020-00247-w
Alvarez Risco A, Mejia CR, Delgado Zegarra J, del Aguila Arcentales S, Arce Esquivel AA, Valladares Garrido MJ, et al. The Peru Approach against the COVID-19 Infodemic: Insights and Strategies. Am J Trop Med Hyg. 2020;103(2):583-6. DOI: https://doi.org/10.4269/ajtmh.20-0536
Pulido CM, Ruiz Eugenio L, Redondo Sama G, Villarejo Carballido B. A new application of social impact in social media for overcoming fake news in health. Int J Environ Res Public Health. 2020;17(7):2430. DOI: https://doi.org/10.3390/ijerph17072430
Moneta ME. Apego y pérdida: Redescubriendo a John Bowlby. Rev Chil Pediatr. 2014;85(3):265-8. DOI: http://dx.doi.org/10.4067/S0370-41062014000300001
Ein Dor T, Hirschberger G. Rethinking attachment theory: from a theory of relationships to a theory of individual and group survival. Curr Dir Psychol Sci. 2016;25(4):223-7. DOI: https://doi.org/10.1177/0963721416650684
Sánchez Moreno F. El sistema nacional de salud en el Perú. Rev Peru Med Exp Salud Publica. 2014;31(4):747-53. Disponible en: https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/129/129
Plataforma digital única del Estado Peruano. Intervienen local clandestino en el que se almacenaba ivermectina falsificada. Lima: Gobierno del Perú; [acceso 13/02/2021]. Disponible en: https://www.gob.pe/institucion/minsa/noticias/294605-intervienen-local-clandestino-en-el-que-se-almacenaba-ivermectina-falsificada
Zavala Flores E, Salcedo Matienzo J. Pre-hospitalary medication in COVID-19 patients from a public hospital in Lima-Peru. Acta Med Peru. 2020;37(3). DOI: https://doi.org/10.35663/amp.2020.373.1277
Centers for Disease Control and Prevention. Cómo protegerse y proteger a los demás. Atlanta: CDC; 2020 [acceso 10/03/2021]. Disponible en: https://espanol.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html
Ipsos. COVID-19 y vacunas. Lima: Ipsos; 2021 feb [acceso 16/02/2021]. Disponible en: https://www.ipsos.com/es-pe/covid-19-y-vacunas-febrero-2021
Lasco G. Medical populism and the COVID-19 pandemic. Glob Public Health. 2020;15(10):1417-29. DOI: https://doi.org/10.1080/17441692.2020.1807581
Downloads
Published
How to Cite
Issue
Section
License
Aquellos autores que tengan publicaciones con esta revista, aceptan los términos siguientes:
- Los autores conservarán sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia Atribución-NoComercial 4.0 Internacional (CC BY-NC 4.0) que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación esta revista.
- Los autores podrán adoptar otros acuerdos de licencia no exclusiva de distribución de la versión de la obra publicada (p. ej.: depositarla en un repositorio institucional o publicarla en un volumen monográfico) siempre que se indique la publicación inicial en esta revista.
- Se permite y recomienda a los autores difundir su obra a través de Internet (p. ej.: en repositorios institucionales o en su página web) antes y durante el proceso de envío, lo cual puede producir intercambios interesantes y aumentar las citas de la obra publicada. (Véase El efecto del acceso abierto). En ese caso, solicitamos que en la cabecera del manuscrito se indique:"Esta es una versión preprint enviada a la Revista Cubana de Información en Ciencias de la Salud http://rcics.sld.cu/"
ENGLISH VERSION
AUTHORS WITH PUBLICATIONS IN THIS JOURNAL ACCEPT THE FOLLOWING TERMS:
- Authors will retain their copyright and will grant the Journal the right of first publication of their work, which will also be subject to a Creative Commons License Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) allowing third parties to share the work as long as the author's name and data about initial publication in this Journal are stated.
- Authors may adopt other license agreements for non-exclusive distribution of the version of the work published (e.g. deposit it in an institutional repository or publish it in a monographic volume), as long as initial publication in this Journal is indicated.
- It is permitted and recommended for authors to disseminate their work on the Internet (e.g. in institutional repositories or their web page) before and during the submission process, which may result in interesting exchanges and increase the number of citations of the published work) (see The effect of open access).
